Given the important role played by CD36 and VLDLR in triglyceride accumulation, identifying the mechanisms that regulate their levels may provide more clues as to how NAFLD develops and progresses. The gene discussed is CD36; the disease is metabolic dysfunction-associated steatotic liver disease.